• Publications
  • Influence
Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.
PURPOSE Brain metastasis (BM) is a leading cause of death from non-small-cell lung cancer (NSCLC). Reasoning that activation of the epidermal growth factor receptor (EGFR) contributes to radiationExpand
  • 332
  • 27
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.
High-throughput and virtual screening are widely used to discover novel leads for drug design. On examination, many screening hits appear non-drug-like: they act noncompetitively, show littleExpand
  • 876
  • 22
  • PDF
A specific mechanism of nonspecific inhibition.
Promiscuous small molecules plague screening libraries and hit lists. Previous work has found that several nonspecific compounds form submicrometer aggregates, and it has been suggested that thisExpand
  • 498
  • 19
  • PDF
Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.
BACKGROUND After brain metastasis resection, whole brain radiotherapy decreases local recurrence, but might cause cognitive decline. We did this study to determine if stereotactic radiosurgery (SRS)Expand
  • 256
  • 17
  • PDF
Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B.
High-throughput screening (HTS) of compound libraries is used to discover novel leads for drug development. When a structure is available for the target, computer-based screening using molecularExpand
  • 359
  • 13
  • PDF
Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity.
PURPOSE We compared proton beam therapy (PBT) with intensity modulated radiation therapy (IMRT) for pediatric craniopharyngioma in terms of disease control, cyst dynamics, and toxicity. METHODS ANDExpand
  • 94
  • 7
Identification of noninvasive imaging surrogates for brain tumor gene-expression modules
Glioblastoma multiforme (GBM) is the most common and lethal primary brain tumor in adults. We combined neuroimaging and DNA microarray analysis to create a multidimensional map of gene-expressionExpand
  • 351
  • 6
  • PDF
Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Some small molecules, often hits from screening, form aggregates in solution that inhibit many enzymes. In contrast, drugs are thought to act specifically. To investigate this assumption, 50Expand
  • 381
  • 5
  • PDF
Lead discovery using molecular docking.
As the structures of more and more proteins and nucleic acids become available, molecular docking is increasingly considered for lead discovery. Recent studies consider the hit-rate enhancement ofExpand
  • 334
  • 4
  • PDF
Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
PURPOSE To describe treatment planning techniques and early clinical outcomes in patients treated with spot scanning proton therapy for chordoma or chondrosarcoma of the skull base. METHODS ANDExpand
  • 31
  • 4